1 | CRSP | CRISPR Therapeutics AG | 2.20% |
2 | UTHR | United Therapeutics Corporation | 2.04% |
3 | ABBV | AbbVie Inc. | 1.96% |
4 | EXEL | Exelixis, Inc. | 1.95% |
5 | MRNA | Moderna, Inc. | 1.93% |
6 | REGN | Regeneron Pharmaceuticals, Inc. | 1.90% |
7 | NBIX | Neurocrine Biosciences, Inc. | 1.90% |
8 | IONS | Ionis Pharmaceuticals, Inc. | 1.87% |
9 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.87% |
10 | VRTX | Vertex Pharmaceuticals Incorporated | 1.87% |
11 | EXAS | Exact Sciences Corporation | 1.86% |
12 | HALO | Halozyme Therapeutics, Inc. | 1.86% |
13 | AMGN | Amgen Inc. | 1.85% |
14 | BMRN | BioMarin Pharmaceutical Inc. | 1.84% |
15 | NTRA | Natera, Inc. | 1.83% |
16 | GILD | Gilead Sciences, Inc. | 1.83% |
17 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.82% |
18 | BIIB | Biogen Inc. | 1.81% |
19 | RVMD | Revolution Medicines, Inc. | 1.81% |
20 | INCY | Incyte Corporation | 1.80% |
21 | INSM | Insmed Incorporated | 1.77% |
22 | BBIO | BridgeBio Pharma, Inc. | 1.76% |
23 | TGTX | TG Therapeutics, Inc. | 1.74% |
24 | RNA | Avidity Biosciences, Inc. | 1.67% |
25 | ROIV | Roivant Sciences Ltd. | 1.66% |
View XBI holdings |